Android app Apple app link

Taysha Gene Therapies, Inc. (TSHA) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$4.76

south_east
-$0.12 (-2.46%)
Day's range
$4.49
Day's range
$5.4

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
11/14/2025 Cantor Fitzgerald Kristen Kluska $13.00 $4.06   220.59%
10/02/2025 Robert W. Baird Jack Allen $12.00 $4.77   151.84%
10/02/2025 Needham Gil Blum $10.00 $4.77   109.86%
08/14/2024 BMO Capital Keith Tapper $5.00 $2.31   116.45%
07/01/2024 Piper Sandler Christopher Raymond $7.00 $2.24   212.5%
05/13/2024 Jefferies Eun Yang $8.00 $2.40   233.33%
04/08/2024 Raymond James Christopher Raymond $9.00 $2.68   235.82%
10/18/2021 Morgan Stanley Matthew Harrison $39.00 $17.63   121.21%
05/18/2021 Cantor Fitzgerald Kristen Kluska $44.00 $21.78   102.02%

Taysha Gene Therapies, Inc. FAQ's

Taysha Gene Therapies, Inc. has been rated by research analysts at Goldman Sachs, UBS, Cantor Fitzgerald, JMP Securities, Robert W. Baird, Needham in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.